Komipharm International Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Komipharm International Co Ltd

Watchlist Manager

Watchlist

Price: 8 620 KRW -2.05% Market Closed

Market Cap: ₩636.9B

K	Komipharm International Co Ltd KOSDAQ:041960	KR
	Prestige International Inc OTC:PGINF	JP
F	Fintech SA WSE:FTH	PL
	SemiLEDs Corp NASDAQ:LEDS	TW
V	Velocity Minerals Ltd F:VMSP	CA
	ProQR Therapeutics NV F:0PQ	NL
	Celon Pharma SA F:8RP	PL
	Centurion Acquisition Corp NASDAQ:ALF	US
G	Gentili Mosconi SpA MIL:GM	IT

Profitability Summary

Komipharm International Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

35%

Sustainable 3Y Average Gross Margin

34%

Gross Margin is Increasing

30% > 35%

Low Operating Margin

Low 3Y Average Operating Margin

Operating Margin is Increasing

-14% > 1%

Negative Net Margin

-5%

Low 3Y Average Net Margin

Net Margin is Increasing

-23% > -5%

Negative Free Cash Flow Margin

-7%

Negative 3Y Average Free Cash Flow Margin

-3%

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.